1 / 10

Autoimmune Disease Diagnostics Market and Forecast 2030

Apelo Consulting has released a report on Autoimmune Disease Diagnostics Market (By Disease Segment, Test Types, Country Analysis), Company Profiles, Financial Insights, Strategy and Recent Developments - Global Forecast to 2030

ApeloConsulting
Download Presentation

Autoimmune Disease Diagnostics Market and Forecast 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoimmune Disease Diagnostics Market 2024-2030 A comprehensive analysis of market size, growth projections, segmentation, regional trends, and key industry players in the global autoimmune diagnostics landscape September 2025 Apelo Consulting

  2. Market Overview& Size Key Market Metrics Market Growth Projection (2024-2030) Market valued at USD 6,583 Million in 2024 Projected to reach USD 10,423 Million by 2030 Robust 7.9% CAGR during the forecast period Growth driven by increasing prevalence of autoimmune conditions advancements and technological Apelo Consulting Page 2

  3. Understanding Autoimmune Diseases Two Major Categories 80+ known types of autoimmune diseases worldwide Abnormal immune response where the body's immune system attacks its own cells and tissues Organ-Specific Systemic Results in deterioration and destruction of healthy tissue Autoantibodies target a specific organ Autoantibodies attack multiple organ systems Common examples: Hashimoto's thyroiditis (organ- specific) and Systemic Lupus Erythematosus (systemic) Example: Hashimoto's thyroiditis attacks thyroid gland Example: SLE affects tissues throughout body Rheumatoid arthritis, Ankylosing spondylitis Type 1 diabetes, Multiple sclerosis Apelo Consulting Page 3

  4. Market Drivers Key Growth Factors Global Autoimmune Disease Prevalence Trend 50+millionAmericans currentlyaffectedby autoimmunedisorders Risingglobalprevalence acrossAsia-Pacific, Europe, anddeveloping regions Supportivegovernment policies andincreased healthcarefunding Growingdemand for advanced diagnostic techniqueswithhigher accuracy Page 4 Apelo Consulting

  5. Recent Market Developments Key Innovations APRIL 2025 Predicta Biosciences Launched its first molecular diagnostic product to optimize the prognosis of multiple myeloma, bringing advanced precision oncology to autoimmune diagnostics Recent breakthroughs in autoimmune diagnostic technologies are transforming patient care and market landscape These innovations represent significant advancements in precision medicine for autoimmune disease management FEBRUARY 2025 Biocon Biologics Launched YESINTEK (ustekinumab-kfce), a biosimilar option to Stelara in the US market for Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis DECEMBER 2024 Quest Diagnostics Introduced a revolutionary autoimmune disease diagnostic service using AI algorithms to analyze test results in real time, providing clinicians with instant feedback on patient status Apelo Consulting Page 5

  6. Disease Segmentation Localized Systemic Autoimmune Diseases Autoimmune Diseases Rheumatoid Arthritis Over 50% of systemic market share (2024) Multiple Sclerosis Highest market share in localized segment (2024) Types of Autoimmune Diseases Autoimmune diseases are categorized into two general groups based on their impact on the body: Type 1 Diabetes Affects pancreatic islet cells Systemic Lupus Erythematosus Affects multiple body systems Organ-specific: Autoantibodies target a specific organ Hashimoto's Thyroiditis Targets the thyroid gland SystemicSclerosis Causes skin and tissue hardening Systemic: Autoantibodies attack multiple organ systems Inflammatory Bowel Disease Affects the digestive tract Ankylosing Spondylitis Primarily affects the spine Multiple Sclerosis (Highest Share) Rheumatoid Arthritis (>50%) Localized vs Systemic Market Share Page 6 ApeloConsulting

  7. Test Types Analysis Key Diagnostic Methods Autoantibody Tests: Captured largest market share in 2024; used for diagnosing various autoimmune disorders Autoimmune Diagnostic Test Types Market Share (2024) Antinuclear Antibody (ANA) Tests: Critical for diagnosing SLE, rheumatoid arthritis in primary care and specialty settings Complete Blood Count (CBC): Essential for diagnosing SLE, Idiopathic Thrombocytopenic Purpura, and Multiple Sclerosis Other Urinalysis, Metabolic comprehensive diagnosis Key Tests: and Panel ESR, CRP, Comprehensive Tests for Apelo Consulting Page 7

  8. Regional Market Analysis Key Regional Insights North America: Largest market share, driven by high prevalence rates and advanced healthcare infrastructure Regional Market Share Distribution (2024) Europe: Second-largest market, with multiple sclerosis prevalence at 83 per 100,000 population Asia-Pacific: Fastest-growing region, driven by large population, increasing disease prevalence, and healthcare investments South America & Middle East/Africa: Emerging markets with significant growth potential Apelo Consulting Page 8

  9. Key Market Players Leading Diagnostics Companies Abbott Laboratories Market Positioning Matrix Siemens Healthineers Roche Diagnostics bioMerieux SA EUROIMMUN AG Bio-Rad Laboratories Quest Diagnostics Thermo Fischer Scientific Inc. Danaher Corporation Apelo Consulting Page 9

  10. Market Forecast & Conclusion Market Expected to Reach USD 10,423 Million by 2030 Strong Growth Drivers Stakeholder Opportunities Investment in AI-powered diagnostic tools Rising prevalence of autoimmune conditions worldwide Technological innovation in diagnostic techniques Expansion into emerging markets in Asia-Pacific region Supportive government policies and healthcare investments Strategic partnerships for comprehensive diagnostic solutions Development of point-of-care testing solutions Expanding awareness and early disease detection initiatives Market Growth Trend (2024-2030) Apelo Consulting Page 10

More Related